Fig. 4From: The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profileFasting plasma glucagon levels (a) and plasma glucagon levels during OGTT after 8 weeks of treatment (b). n = 8–10 rats per group. Statistical analysis between groups were performed as a one-way ANONA followed by Tukey’s post-hoc test. All data are means ± SEMBack to article page